JPMorgan on Novavax (NVAX): 'Share Gain Likely Short-Lived Given Gap 2025 Commercial Year'
Go back to JPMorgan on Novavax (NVAX): 'Share Gain Likely Short-Lived Given Gap 2025 Commercial Year'| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 7.93 -0.21 (2.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.14 | 52 Week High | $9.23 | |||
| Open | $8.13 | 52 Week Low | $1.16 | |||
| Day High | $8.13 | P/E | N/A | |||
| Day Low | $7.92 | EPS | $-0.30 | |||
| Volume | 1,028,708 | |||||
